CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-15 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-08-16 | GILL DAVID N Director | Purchase | +3,000 | $1.81 | $5K | 14,000 |
| 2017-06-13 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-05-16 | GILL DAVID N Director | Purchase | +3,000 | $1.68 | $5K | 11,000 |
| 2016-12-16 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-15 | GILL DAVID N Director | Purchase | +3,000 | $1.65 | $5K | 8,000 |
| 2016-12-09 | GILL DAVID N Director | Purchase | +5,000 | $1.92 | $10K | 5,000 |
| 2015-06-24 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2015-02-02 | GILL DAVID N Director | Grant or award · Employee Stock Option (Right to Buy) | +13,200 | 13,200 |
Page 1 of 1 · 9 trades